or Try an Advanced Search...

    Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 8.65 3.47% 0.29
    ACRV closed up 3.47 percent on Wednesday, May 15, 2024, on 4 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ACRV trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 3.47%
    20 DMA Resistance Bearish 2.00%
    Wide Bands Range Expansion 2.00%
    180 Bullish Setup Bullish Swing Setup -1.37%
    Outside Day Range Expansion -1.37%
    Wide Bands Range Expansion -1.37%
    Oversold Stochastic Weakness -1.37%
    Older End-of-Day Signals for ACRV ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 18 hours ago
    Possible Inside Day about 18 hours ago
    Up 3% about 20 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Rose Above 10 DMA about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ACRV Chart by TradingView
    Basic chart:

    Profile

    Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

    Is ACRV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Acrivon Therapeutics GAAP EPS of -$0.73 beats by $0.11
    May 14 Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    May 10 Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?
    May 9 While institutions own 26% of Acrivon Therapeutics, Inc. (NASDAQ:ACRV), private equity firms are its largest shareholders with 50% ownership
    Apr 24 Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
    Apr 17 Acrivon Therapeutics files to sell 15.29M shares of common stock for holders
    Apr 17 Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
    Apr 10 Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resis...
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 9 Dow Dips 150 Points; Laser Photonics Shares Spike Higher
    See more ACRV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.03
    52 Week Low 3.19
    Average Volume 957,776
    200-Day Moving Average 6.91
    50-Day Moving Average 7.69
    20-Day Moving Average 8.94
    10-Day Moving Average 8.59
    Average True Range 0.99
    RSI (14) 51.22
    ADX 34.01
    +DI 26.17
    -DI 14.74
    Chandelier Exit (Long, 3 ATRs) 8.55
    Chandelier Exit (Short, 3 ATRs) 10.76
    Upper Bollinger Bands 10.29
    Lower Bollinger Band 7.59
    Percent B (%b) 0.39
    BandWidth 30.18
    MACD Line 0.13
    MACD Signal Line 0.29
    MACD Histogram -0.1626
    Fundamentals Value
    Market Cap 191.98 Million
    Num Shares 22.2 Million
    EPS -2.26
    Price-to-Earnings (P/E) Ratio -3.83
    Price-to-Sales 0.00
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.30
    Resistance 3 (R3) 9.24 8.98 9.19
    Resistance 2 (R2) 8.98 8.81 9.00 9.15
    Resistance 1 (R1) 8.81 8.71 8.90 8.87 9.12
    Pivot Point 8.55 8.55 8.59 8.57 8.55
    Support 1 (S1) 8.38 8.38 8.47 8.44 8.18
    Support 2 (S2) 8.12 8.28 8.14 8.15
    Support 3 (S3) 7.95 8.12 8.11
    Support 4 (S4) 8.01